You are here

Joint Statement on Clinical Trial Oversight in Canada

Health Canada (HC) and the Canadian Institutes of Health Research (CIHR), with the collaboration and participation of the Canadian Association of Research Ethics Boards (CAREB-ACCER), issued a Joint Statement on Clinical Trials Oversight in Canada recognizing the urgent need to conduct clinical trials to evaluate the safety and efficacy of a drug, a vaccine or a medical device in treating, preventing, mitigating or diagnosing COVID-19.

For more details the Joint Statement, please review the following: 

ENG: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/announcements/joint-statement-clinical-trial-oversight-canada.html

FR: https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/annonces/declaration-commune-surveillance-essais-cliniques-canada.html